Economic evaluation of aclidinium bromide in the management of moderate to severe COPD: an analysis over 5 years

PURPOSE: Aclidinium bromide is a long-acting muscarinic antagonistic used in maintenance treatment of chronic obstructive pulmonary disease (COPD). A model-based health economic study evaluated the cost-effectiveness of aclidinium 400 μg bid as an alternative to tiotropium 18 μg od for this indicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Karabis, Andreas, Mocarski, Michelle, Eijgelshoven, Indra, Bergman, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984059/
https://www.ncbi.nlm.nih.gov/pubmed/24741321
http://dx.doi.org/10.2147/CEOR.S57904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984059/
https://www.ncbi.nlm.nih.gov/pubmed/24741321
http://dx.doi.org/10.2147/CEOR.S57904

Ejemplares similares